You are here: Welcome to the MPKB » Welcome to the MPKB » Diseases » Chronic Lyme disease
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:diseases:lyme [02.28.2019] – [Data] sallieqhome:diseases:lyme [08.02.2019] – [Other treatments] sallieq
Line 39: Line 39:
  
 TOTALS: 864 members;573 report success; 119 report no success; and for 172 results are not clear.  TOTALS: 864 members;573 report success; 119 report no success; and for 172 results are not clear. 
 +
 SUCCESS RATES:  SUCCESS RATES: 
 Over all success rate 66.32% Over all unsuccessful 13.77% Over all unsure 19.91%  Over all success rate 66.32% Over all unsuccessful 13.77% Over all unsure 19.91% 
Line 69: Line 70:
   * **[[home:othertreatments:rife|Rife]]** – There is no scientific evidence that the use of a Rife device has the intended effect on infectious bacteria. Instead, most patients using Rife are likely administering themselves nothing more than an expensive placebo.   * **[[home:othertreatments:rife|Rife]]** – There is no scientific evidence that the use of a Rife device has the intended effect on infectious bacteria. Instead, most patients using Rife are likely administering themselves nothing more than an expensive placebo.
  
 +
 +==== Disulfiram ====
 +
 +
 +[[https://www.lymedisease.org/disulfiram-kinderlehrer/?fbclid=IwAR2CQcqG97LK_qsGh1QZD37VrD2oQecR70cZKyXlidgdMIyGOWcPgKdLAWA|Activity of disulfiram]]
 +
 +[[https://www.mdpi.com/2079-6382/8/2/72/htm?fbclid=IwAR3l19rcHXqfvUcYXUqlk9F18kZqwGX_QsiJPdgfPrIUYe15SUAAGKltfTo|Three cases]]
 +
 +
 +[[https://clinicaltrials.gov/ct2/show/NCT03891667|Study to examine the safety of disulfiram among patients with post-treatment Lyme disease Sx]]
 +
 +Screening to identify potent drug candidates that can target the Borrelia persisters.(({{pubmed>long:27103785}}))
  
  
Line 86: Line 99:
  
 W. Ian Lipkin's team sampled 286 adult ticks from the two counties in New York State where Lyme disease is endemic, looking for the prevalence of polymicrobial infection with //Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia microti, Borrelia miyamotoi,// and Powassan virus.(({{pubmed>long:19725770}})) Seventy-one percent of the ticks harbored at least one organism; 30% had a polymicrobial infection. Infections with three microbes were detected in 5% of the ticks. One tick was infected with four organisms. W. Ian Lipkin's team sampled 286 adult ticks from the two counties in New York State where Lyme disease is endemic, looking for the prevalence of polymicrobial infection with //Borrelia burgdorferi, Anaplasma phagocytophilum, Babesia microti, Borrelia miyamotoi,// and Powassan virus.(({{pubmed>long:19725770}})) Seventy-one percent of the ticks harbored at least one organism; 30% had a polymicrobial infection. Infections with three microbes were detected in 5% of the ticks. One tick was infected with four organisms.
 +
 +
 +We collected data from an online survey of 200 of our patients, which evaluated the efficacy of dapsone (diaminodiphenyl sulfone, ie, DDS) combined with other antibiotics and agents that disrupt biofilms for the treatment of chronic Lyme disease/post-treatment Lyme disease syndrome (PTLDS). We also collected aggregate data from direct retrospective chart review, including laboratory testing for Lyme, other infections, and associated tick-borne coinfections. (({{pubmed>long:30863136}}))
  
 === Australian ticks === === Australian ticks ===
home/diseases/lyme.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.